CC
AMGN icon

ClearArc Capital’s Amgen AMGN Stock Holding History

ClearArc Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.34M Sell
5,543
-2,632
-32% -$580K 0.52% 46
2019
Q3 		$1.58M Sell
8,175
-126
-2% -$24.2K 0.46% 52
2019
Q2 		$1.53M Sell
8,301
-1,294
-13% -$232K 0.45% 50
2019
Q1 		$1.82M Sell
9,595
-511
-5% -$97.6K 0.49% 49
2018
Q4 		$1.97M Sell
10,106
-10,629
-51% -$2.07M 0.59% 39
2018
Q3 		$4.3M Sell
20,735
-2,085
-9% -$411K 0.56% 44
2018
Q2 		$4.21M Sell
22,820
-28
-0.1% -$4.95K 0.59% 42
2018
Q1 		$3.9M Sell
22,848
-1,351
-6% -$248K 0.59% 43
2017
Q4 		$4.21M Buy
24,199
+579
+2% +$102K 0.57% 45
2017
Q3 		$4.4M Sell
23,620
-1,756
-7% -$311K 0.66% 40
2017
Q2 		$4.37M Buy
25,376
+609
+2% +$99.1K 0.71% 40
2017
Q1 		$4.06M Buy
24,767
+1,302
+6% +$216K 0.68% 41
2016
Q4 		$3.43M Buy
23,465
+354
+2% +$53.3K 0.62% 42
2016
Q3 		$3.85M Buy
23,111
+833
+4% +$141K 0.73% 35
2016
Q2 		$3.39M Buy
22,278
+212
+1% +$33K 0.66% 40
2016
Q1 		$3.31M Buy
22,066
+954
+5% +$142K 0.7% 33
2015
Q4 		$3.43M Sell
21,112
-304
-1% -$47.8K 0.72% 29
2015
Q3 		$2.96M Sell
21,416
-1,915
-8% -$302K 0.62% 36
2015
Q2 		$3.58M Buy
23,331
+2,844
+14% +$456K 0.66% 34
2015
Q1 		$3.27M Buy
20,487
+508
+3% +$80K 0.67% 30
2014
Q4 		$3.18M Buy
19,979
+1,680
+9% +$262K 0.65% 30
2014
Q3 		$2.57M Sell
18,299
-2,430
-12% -$317K 0.58% 38
2014
Q2 		$2.45M Buy
20,729
+99
+0.5% +$11.5K 0.57% 42
2014
Q1 		$2.54M Buy
20,630
+1,431
+7% +$174K 0.63% 36
2013
Q4 		$2.19M Sell
19,199
-1,049
-5% -$119K 0.57% 45
2013
Q3 		$2.27M Sell
20,248
-2,486
-11% -$270K 0.63% 38
2013
Q2 		$2.24M Buy
+22,734
New +$2.36M 0.6% 41

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ClearArc Capital's AMGN Position: Q4 2019 in Review

ClearArc Capital reduced its Amgen (AMGN) stake by 32% in Q4 2019, selling an estimated $580K and leaving 5,543 shares worth $1.34M. The position accounts for 0.52% of the portfolio, ranked #46.

ClearArc Capital first reported a position in AMGN in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.4M in Q3 2017. 2,108 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.

  • ClearArc Capital held 5,543 shares of Amgen worth $1.34M as of Q4 2019.
  • ClearArc Capital sold 2,632 Amgen shares in Q4 2019, an estimated $580K.
  • Amgen made up 0.52% of ClearArc Capital's portfolio in Q4 2019, its #46 holding.
  • ClearArc Capital first reported a position in Amgen in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Amgen position peaked at $4.4M in Q3 2017.
  • 2,108 funds tracked by Wall St. Rank held Amgen as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.